Bar Harbor Wealth Management has acquired a significant position in
Eastman Chemical Company. A director at the company also chose to take his payment in the form of phantom stock units, displaying immense confidence in the company’s potential. These units were added and deferred several times. However, the company’s stock performance has been mixed with both out- and underperforming days. The
price target of Eastman Chemical has been raised by financial institution, UBS, to
$88.00. Various wealth management firms have been adjusting their stakes in Eastman Chemical, with some taking a bullish stance and others selling off their positions. Despite a fall in both the EPS and revenue in Q4 2025, the company has highlighted strategic cost reductions. Eastman Chemical has shown promising signs of improvement, with increased attempts at cost cuts and ETP execution. The company has also been focusing on sustainability efforts, however, the company is facing challenges due to its extensive use of debt. The upcoming Q2 2025 dividend announcement will be an event to watch out for. Despite softer demand signals post-earnings sell-off, investors are closely monitoring Eastman Chemical's 2026 self-help plan and cash-return commitments.
Eastman Chemical Company EMN News Analytics from Fri, 27 Jun 2025 07:00:00 GMT to Sat, 11 Apr 2026 07:43:20 GMT -
Rating 0
- Innovation -3
- Information 6
- Rumor -2
